Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Polycomb Repressive Complex 2 (PRC2) is a multi-protein complex that mediates gene silencing through the methylation of histone H3 at lysine 27 (H3K27me3). It plays crucial roles in development, cell differentiation, and disease. The core complex comprises EZH1/EZH2 (catalytic subunit), SUZ12, and EED. Accessory proteins like RBBP4/7, AEBP2, and JARID2 modulate its activity. PRC2 dysregulation is implicated in cancer and neurodegenerative disorders.
Inhibition of H3K27 methylation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polycomb Repressive Complex 2 (PRC2).